Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease

DOI PDF PDF 4 Citations
  • Erin F Balcom
    Division of Neurology, University of Alberta, Edmonton, Alberta, Canada
  • Avindra Nath
    Section of Infections of the Nervous System, NINDS-NIH, Bethesda, MD, USA
  • Christopher Power
    Division of Neurology, University of Alberta, Edmonton, Alberta, Canada

Search this article

Description

<jats:title>Abstract</jats:title><jats:p>Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-2 infection and is associated with both acute and chronic disorders affecting the nervous system. Acute neurological disorders affecting patients with COVID-19 range widely from anosmia, stroke, encephalopathy/encephalitis, and seizures to Guillain–Barré syndrome. Chronic neurological sequelae are less well defined although exercise intolerance, dysautonomia, pain, as well as neurocognitive and psychiatric dysfunctions are commonly reported. Molecular analyses of CSF and neuropathological studies highlight both vascular and immunologic perturbations. Low levels of viral RNA have been detected in the brains of few acutely ill individuals. Potential pathogenic mechanisms in the acute phase include coagulopathies with associated cerebral hypoxic-ischaemic injury, blood–brain barrier abnormalities with endotheliopathy and possibly viral neuroinvasion accompanied by neuro-immune responses. Established diagnostic tools are limited by a lack of clearly defined COVID-19 specific neurological syndromes. Future interventions will require delineation of specific neurological syndromes, diagnostic algorithm development and uncovering the underlying disease mechanisms that will guide effective therapies.</jats:p>

Journal

  • Brain

    Brain 144 (12), 3576-3588, 2021-08-16

    Oxford University Press (OUP)

Citations (4)*help

See more

Report a problem

Back to top